SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-257207
Filing Date
2022-10-04
Accepted
2022-10-04 07:32:05
Documents
16
Period of Report
2022-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d248686d8k.htm   iXBRL 8-K 32430
2 EX-99.1 d248686dex991.htm EX-99.1 13868
7 GRAPHIC g248686g07f09.jpg GRAPHIC 3124
8 GRAPHIC g248686g56d68.jpg GRAPHIC 2801
  Complete submission text file 0001193125-22-257207.txt   221717

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20221003.xsd EX-101.SCH 3144
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20221003_def.xml EX-101.DEF 13953
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20221003_lab.xml EX-101.LAB 23052
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20221003_pre.xml EX-101.PRE 14831
10 EXTRACTED XBRL INSTANCE DOCUMENT d248686d8k_htm.xml XML 5689
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 221289729
SIC: 2836 Biological Products, (No Diagnostic Substances)